Aarti Drugs Schedules Q2 & H1FY27 Earnings Conference Call
Aarti Drugs Ltd 路 Intimation 路 04 Nov 2026, 11:00 am
Aarti Drugs Schedules Q2 & H1FY27 Earnings Conference Call Aarti Drugs Limited will host its Q2 & H1FY27 earnings conference call for investors and analysts on 4th Nov'26 at 11:00 AM IST to discuss financial performance for the quarter and half year ended 30th Sep'26. The management team, including Joint Managing Director Harshit Savla, Whole-time Director Harit Shah, Managing Director Adhish Patil, and Pinnacle Life Science Managing Director Vishwa Savla, will represent the company. Dial-in access is available across India, the US, the UK, Singapore, and Hong Kong.
Original exchange filing (PDF)
More announcements from Aarti Drugs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Transcript of Q2&H1 FY27 Earning Conference call 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations, 2015 路 06 Nov 2026
- Audio recording for conference call for Analyst and Investors 路 05 Nov 2026
- Investor Presentation for Q2 FY27 路 04 Nov 2026
- Press release on Financial results for Quarter and Half year ended September 2026 路 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
